Margareta Reis (Former)
1 – 20 of 22
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Differences in antipsychotic treatment between depressive patients with and without a suicide attempt
(
- Contribution to journal › Article
- 2020
-
Mark
Recognition of personality disorder and anxiety disorder comorbidity in patients treated for depression in secondary psychiatric care
(
- Contribution to journal › Article
-
Mark
A Relative Bioavailability Study of Two Misoprostol Formulations Following a Single Oral or Sublingual Administration
(
- Contribution to journal › Article
-
Mark
Allt fler kvinnor i fertil ålder tar antidepressiva läkemedel
(
- Contribution to journal › Article
- 2019
-
Mark
A Compilation of Serum Concentrations of 12 Antipsychotic Drugs in a Therapeutic Drug Monitoring Setting
(
- Contribution to journal › Article
- 2017
-
Mark
Impact of generic substitution on levetiracetam serum concentration : A prospective study in an outpatient setting
(
- Contribution to journal › Article
- 2016
-
Mark
Antipsychotics - Postmortem fatal and non-fatal reference concentrations
(
- Contribution to journal › Article
-
Mark
Ongoing Pharmacological Management of Chronic Pain in Pregnancy
(
- Contribution to journal › Article
- 2015
-
Mark
Use of tramadol in early pregnancy and congenital malformation risk.
(
- Contribution to journal › Article
- 2014
-
Mark
Adverse drug reactions differ between CYP2D6 intermediate and extensive metabolizers in patients treated with antidepressive drugs
2014) CINP World Congress 2014(
- Contribution to conference › Poster
- 2013
-
Mark
The Use of Central Nervous System Active Drugs During Pregnancy.
(
- Contribution to journal › Article
- 2012
-
Mark
Neonatal Complications After Maternal Concomitant Use of SSRI and Other Central Nervous System Active Drugs During the Second or Third Trimester of Pregnancy.
(
- Contribution to journal › Article
- 2008
-
Mark
Maternal Use of Antipsychotics in Early Pregnancy and Delivery Outcome.
(
- Contribution to journal › Article
- 2007
-
Mark
Therapeutic drug monitoring of escitalopram in an outpatient setting
(
- Contribution to journal › Article
- 2005
-
Mark
Inter- and intraindividual pharmacokinetic variations of mirtazapine and its N-demethyl metabolite in patients treated for major depressive disorder - A 6-month therapeutic drug monitoring study
(
- Contribution to journal › Article
- 2004
-
Mark
Compliance with SSRI medication during 6 months of treatment for major depression: an evaluation by determination of repeated serum drug concentrations
(
- Contribution to journal › Article
-
Mark
Serum disposition of sertraline, N-desmethylsertraline and paroxetine: A pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression
(
- Contribution to journal › Article
- 2003
-
Mark
Therapeutic Drug Monitoring of Racemic Citalopram: A 5-Year Experience in Sweden, 1992-1997.
(
- Contribution to journal › Article
- 2002
-
Mark
Serum levels of citalopram and its main metabolites in adolescent patients treated in a naturalistic clinical setting
(
- Contribution to journal › Article
-
Mark
Therapeutic drug monitoring data on olanzapine and its N-demethyl metabolite in the naturalistic clinical setting
(
- Contribution to journal › Article